Willis Towers Watson (WLTW) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Achieved 3% organic revenue growth, 8% total revenue growth to $2.41B, 70bps adjusted operating margin expansion, and 19% adjusted diluted EPS growth year-over-year in Q1 2026.
Diluted EPS increased 33% to $3.10; adjusted diluted EPS up 19% to $3.72.
Enhanced efficiency and productivity through AI, driving operating leverage and free cash flow margin improvement.
Returned $300M to shareholders via share repurchases and paid $88M in dividends in Q1 2026.
Supported clients through macroeconomic volatility while executing strategic priorities.
Financial highlights
Revenue rose 8% year-over-year to $2.41B in Q1 2026.
Net income increased 27% to $303M; adjusted net income up 13% to $357M.
Adjusted diluted EPS grew 19% to $3.72; adjusted operating margin expanded to 22.3%.
Free cash flow improved to -$65M from -$86M year-over-year.
Net cash from operating activities was -$10M, up from -$35M in Q1 2025.
Outlook and guidance
Targeting mid-single digit organic revenue growth and continued annual adjusted operating margin expansion.
Expecting ~100bps average annual margin expansion in Risk & Broking over next two years; incremental margin expansion in Health, Wealth & Career.
Share repurchases of $1.0B or greater anticipated for 2026, subject to market conditions.
Newfront acquisition expected to be ~$0.10 dilutive to adjusted EPS in 2026, with $250M post-close revenue and ~26% adjusted EBITDA margin.
Foreign exchange expected to provide a ~$0.35 tailwind to adjusted diluted EPS for full year 2026.
Latest events from Willis Towers Watson
- Six major proposals, board refreshment, strong performance, and enhanced risk oversight highlighted.WLTW
Proxy filing27 Mar 2026 - Key votes include director elections, auditor ratification, and share plan amendments.WLTW
Proxy filing27 Mar 2026 - Organic growth and margin expansion drove strong results despite divestiture impacts.WLTW
Q4 20253 Feb 2026 - Q2 2024 delivered 6% organic growth, margin expansion, and raised 2024 guidance.WLTW
Q2 20242 Feb 2026 - Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WLTW
Q3 202417 Jan 2026 - Sustained organic growth and margin expansion driven by innovation, efficiency, and portfolio optimization.WLTW
CMD 202412 Jan 2026 - 5% organic growth, margin gains, $473M savings, and $1.5B buyback planned for 2025.WLTW
Q4 20248 Jan 2026 - $1.3B acquisition leverages advanced tech and talent for $35M in synergies and U.S. growth.WLTW
M&A Announcement10 Dec 2025 - 2025 AGM to vote on directors, auditors, executive pay, share issuance, and pre-emption rights.WLTW
Proxy Filing1 Dec 2025